Your search for

34 results were returned

  1. Legal news
    04 June 2019
    Investing in the future of cannabis in the UK - lessons from the German model
    www.twobirds.com/en/news/articles/2019/uk/investing-in-the-future-of-cannabis-in-the-uk--lessons-from-the-german-model

    The excitement around the potential for the UK cannabis market – medicinal and nutritional – to continue opening up has really intensified in the first half of 2019.

  2. Legal news
    16 May 2019
    Report from Med-Tech Innovation Expo 2019
    www.twobirds.com/en/news/articles/2019/uk/bird-and-birds-ewan-grist-chris-de-mauny-and-toby-bond-spoke-at-the-med-tech-innovation-expo

    Ewan explored the legal issues which arise at various stages of the lifecycle of a medical device; from product concept, though prototyping, testing, refinement, manufacture, marketing and placing on the market.

  3. Legal news
    24 June 2019
    From e-health to digital Health: Telemedicine, Electronic Healthcare File, Artificial Intelligence
    www.twobirds.com/en/news/articles/2019/global/from-e-health-to-digital-health-telemedicine-electronic-healthcare-file-artificial-intelligence

    In the last five decades we have been assisting on the digitalization of society and consequently of the healthcare sector; we have been using terms such as eHealth, medical informatics, health informatics, ...

  4. Legal news
    24 May 2019
    Can CRISPR save the Cavendish?
    www.twobirds.com/en/news/articles/2019/global/can-crispr-save-the-cavendish

    The world's most popular banana is dying. Scientists are using the gene-editing mechanism CRISPR to try and save it from extinction.

  5. Legal news
    06 September 2019
    China passed new amendments to the Drug Administration Law
    www.twobirds.com/en/news/articles/2019/global/china-passed-new-amendments-to-the-drug-administration-law

    On 26 August 2019, China's National People's Congress passed the final amendments to the Drug Administration Law ("DAL"), which will take effect on 1 December 2019. The DAL was first enacted in 1984, then substantively ...

  6. Legal news
    08 May 2019
    Manufacturing and stockpiling waiver set to limit rights of holders of SPCs for medicines
    www.twobirds.com/en/news/articles/2019/global/manufacturing-and-stockpiling-waiver-set-to-limit-rights-of-holders-of-spcs-for-medicines

    On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").

  7. Legal news
    05 February 2019
    "Effective enforcement of EU competition rules in the pharmaceutical law remains a matter of high priority…"
    www.twobirds.com/en/news/articles/2019/global/effective-enforcement-of-eu-competition-rules-in-pharmaceutical-law

    So notes the Commission's report on competition enforcement in the pharmaceutical sector (2009-2017) published at the end of January 2019.

  8. Legal news
    18 September 2019
    When does speaking badly about your competitors become a competition law problem?
    www.twobirds.com/en/news/articles/2019/global/when-does-speaking-badly-about-your-competitors-become-a-competition-law-problem

    Following seminal “denigration” cases from the French, Danish and Italian competition authorities, our competition team looks into this new practice of exclusionary abuse.

  9. Legal news
    27 March 2019
    Supreme Court holds Dosage Regime Patent Obvious
    www.twobirds.com/en/news/articles/2019/global/supreme-court-holds-dosage-regime-patent-obvious

    Today in Actavis v ICOS the Supreme Court unanimously ruled that the ICOS patent for a Tadalafil dosing regime was invalid. Lord Hodge gave the only judgment, with Lady Hale, Lord Kerr, Lord Sumption and Lord Briggs in ...

  10. Legal news
    02 July 2019
    Transfer of value: amendments to the French “anti-gift” provisions by the draft Health Act
    www.twobirds.com/en/news/articles/2019/global/transfer-of-value-amendments-to-the-french-anti-gift-provisions-by-the-draft-health-act

    The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the health sector are allowed to provide advantages, in cash or in kind, to healthcare professionals ("HCPs”)